Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Vistin Pharma Asa | LSE:0RAM | London | Ordinary Share | NO0010734122 | VISTIN PHARMA ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 11.25 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 438.33M | 45.6M | 1.0282 | 10.94 | 498.88M |
From Nov 2023 to Nov 2024
Pactum Vekst AS has on March 22, 2024 sold 527 960 shares in Vistin Pharma ASA at a price of NOK 22,10 per share. Espen W. Marcussen, Chair of the board in Pactum Vekst AS, is a primary insider and board member of Vistin Pharma ASA. Pactum Vekst AS is fully owned by Pactum AS. The shares in Vistin Pharma are sold to one of Pactum’s shareholders, as part of a share buy-back process in Pactum.
After the transaction, Pactum Vekst AS owns 2 991 773 shares in Vistin Pharma ASA.
Please see attached document in accordance with the Market Abuse Regulation article 19.
This notification has been submitted pursuant to the Securities Trading Act section 5-12.
Attachment
1 Year Vistin Pharma Asa Chart |
1 Month Vistin Pharma Asa Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
